Recent advances in targeting LRRK2 for Parkinson’s disease treatment

Abstract Parkinson’s disease (PD) is a neurodegenerative disease with severe movement problems. Current treatments mainly focus on symptom management by reducing dopaminergic pathways in the brain. Despite these therapies, ongoing disease progression undermines the effectiveness of prevalent approac...

全面介紹

書目詳細資料

Principais autores:	Mahsa Karami, Pantea Majma Sanaye, Atousa Ghorbani, Roshanak Amirian, Pouya Goleij, Mehregan Babamohamadi, Zhila Izadi
格式:	Artigo
語言:	Inglês
出版:	BMC 2025-07-01
叢編:	Journal of Translational Medicine
主題:	Parkinson’s disease LRRK2 Neurodegenerative diseases Autophagy PROTAC Mitochondrial dysfunction
在線閱讀:	https://doi.org/10.1186/s12967-025-06354-0
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!